Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18

Showing 18 citing articles:

Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways
Noha Nabil Mohammed, Mariane G. Tadros, Mina Y. George
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 777-794
Open Access | Times Cited: 20
Polyphenols: Natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective
Zhenmin Li, Ting Zhao, Mingqin Shi, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 18
Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
Anna D. Grabowska, Mateusz Wątroba, Joanna Witkowska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11640-11640
Open Access | Times Cited: 9
Targeted quantitative metabolic profiling of brain-derived cell cultures by semi-automated MEPS and LC-MS/MS
Michele Protti, Marco Cirrincione, Sarah Palano, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115757-115757
Open Access | Times Cited: 8
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Jenny Garmendia, Claudia Valentina De Sanctis, Viswanath Das, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 1080-1109
Open Access | Times Cited: 6
In Silico Molecular Docking and ADMET Analysis for Drug Development of Phytoestrogens Compound with Its Evaluation of Neurodegenerative Diseases
Faisal Akhmal Muslikh, Reyhan Rahma Samudra, Burhan Ma’arif, et al.
Borneo Journal of Pharmacy (2022) Vol. 5, Iss. 4, pp. 357-366
Open Access | Times Cited: 9
Vitamin D3 actions on astrocyte cells: A target for therapeutic strategy in Parkinson’s disease?
Erlânia Alves de Siqueira, Emanuel Paula Magalhães, Ramon Róseo Paula Pessoa Bezerra de Menezes, et al.
Neuroscience Letters (2022) Vol. 793, pp. 136997-136997
Closed Access | Times Cited: 8
Sleep-Disturbance-Induced Microglial Activation Involves CRH-Mediated Galectin 3 and Autophagy Dysregulation
Liyang Guo, Kirstin Reed, Ashley Carter, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 160-160
Open Access | Times Cited: 8
Advanced nanomaterials for dye sensitized solar cells
Hakimeh Teymourinia, Vahid Amani
Elsevier eBooks (2024), pp. 41-67
Closed Access | Times Cited: 1
New models of Parkinson’s like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors
Francesca De Chirico, Eleonora Poeta, Giorgia Babini, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 7
RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders
Abhishek Guha, Mohammed Amir Husain, Ying Si, et al.
Glia (2022) Vol. 71, Iss. 3, pp. 485-508
Closed Access | Times Cited: 6
Fibrillation of α‐synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N‐terminal acetylation and familial Parkinson's disease mutations
José Raphael Monteiro Neto, Vanderlei de Araújo Lima, Cristian Follmer
FEBS Journal (2023) Vol. 291, Iss. 6, pp. 1151-1167
Closed Access | Times Cited: 3
Stem cell therapy as a novel concept to combat CNS disorders
Rahul Kumar, Srushti Mahajan, Ujala Gupta, et al.
Elsevier eBooks (2024), pp. 175-206
Closed Access
Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut–Brain Axis and Helicobacter pylori Infection
Marina Boziki, Paschalis Theotokis, Evangelia Kesidou, et al.
Neurology International (2024) Vol. 16, Iss. 6, pp. 1750-1778
Open Access
Innate Immunity in Cardiovascular Diseases – Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Innate Immunity in Cardiovascular Diseases – Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Parkinson’s Disease: An Overview on its Neurophysiologi-cal Effects and Potential Treatments
Santosha Pochiraju, Mia Edgerton
Journal of Student Research (2022) Vol. 11, Iss. 4
Open Access
Page 1

Scroll to top